Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Oncology|September 13, 2021
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative StudyTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2015
Proton beam therapy for metastatic liver tumorsNobuyoshi Fukumitsu, Toshiyuki Okumura, Daichi Takizawa, et al.
Anticancer Research|June 29, 2026
Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-BevacizumabNaoyuki Hasegawa, Sodai Hoshiai, Takeshi Yamada, et al.
Clinical and Translational Radiation Oncology|June 21, 2021
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in JapanYoshiko Oshiro, Masashi Mizumoto, Yuta Sekino, et al.
Internal Medicine (Tokyo, Japan)|May 14, 2025
A Case of Methylprednisolone-induced Anaphylaxis in Acute Hepatitis B: A Case Report and Literature ReviewYuki Tamura, Daichi Takizawa, Kaho Honda, et al.
Japanese Journal of Clinical Oncology|October 15, 2016
Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancerEi-Ichiro Takaoka, Jun Miyazaki, Hitoshi Ishikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 25, 2019
Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective studyTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Cancers|October 14, 2020
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression TreatmentTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2025
Evaluation of the Efficacy of Lusutrombopag for Chronic Liver Disease Based on Pre-Treatment Platelet Counts: A Retrospective Multicenter StudyTakayoshi Suga, Satoru Kakizaki, Atsushi Naganuma, et al.
DEN Open|March 21, 2022
Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct-acting antiviralsSatoshi Takakusagi, Naoto Saito, Takashi Ueno, et al.
Pageof 7